← All investors

5AM Ventures

VCπŸ‡ΊπŸ‡Έ United States

Investment thesis

Builds next-generation life sciences companies addressing important healthcare needs. Works hands-on with portfolio companies (sometimes taking operating roles) and incubates breakthrough science pre-Series A via its 4:59 Initiative to establish proof-of-concept for Series A financing.

Notable portfolio

AmbrxFlexus BiosciencesPandion Therapeutics

Sector focus

Life sciencesBiotechTherapeuticsDrug deliveryResearch tools